Literature DB >> 850196

The release of vasopressin by nicotine: further studies on its site of action.

E Castro de Souza, M Rocha E Silva.   

Abstract

1. In cats anaesthetized with chloralose the release of vasopressin in response to nicotine injections was examined. This release was measured by assaying the hormone in samples of venous blood. 2. Nicotine injections were given by three different routes, namely intravertebral, intracarotid and intravenous. The first two represent close arterial routes to the medulla and to the hypothalamus, respectively, the effects of which could be compared to those following intravenous, i.e. systemic, administration. 3. Nicotine was found to increase vasopressin secretion by all three routes of administration. The potency of intracarotid injections was found to be no greater than that of intravenous injections, in sharp contrast to intravertebral injections, which were 4-5 times more potent. 4. In terms of vascular effects, intracarotid and intravenous injections of nicotine were found to increase blood pressure, whereas intravertebral injections of low doses of nicotine were always followed by a fall in blood pressure. Higher doses of intravertebral nicotine produce mixed results, pressor or depressor, in different animals. 5. The vasodepressor effect of intravertebral nicotine was part of a cardiovascular response which included a lowering of total peripheral resistance and of stroke work, whereas the cardiac output, the heart rate and the stroke volume remained essentially unchanged. 6. These results clearly indicate that a medullary area, which has been previously described, is the most sensitive site for the vasopressin releasing action of nicotine and that systemic administration of the drug induces vasopressin secretion by virtue of its action on the medulla, rather than directly on the supraoptic nucleus. 7. The results also indicate that the vasodepressor effect which follows the application of nicotine on the medulla is chiefly due to vasodilator effects on systemic blood vessels, with practically no action on cardiac function. The significance of these results is discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 850196      PMCID: PMC1307821          DOI: 10.1113/jphysiol.1977.sp011717

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  18 in total

1.  A method for the assay of very small amounts of antidiuretic activity with a note on the antidiuretic titre of rat's blood.

Authors:  S E DICKER
Journal:  J Physiol       Date:  1953-10       Impact factor: 5.182

2.  Antidiuretic Action of Nicotine.

Authors:  J H Burn; L H Truelove; I Burn
Journal:  Br Med J       Date:  1945-03-24

3.  The inhibitory effect of acetylcholine on water diuresis in the dog, and its pituitary transmission.

Authors:  M Pickford
Journal:  J Physiol       Date:  1939-02-14       Impact factor: 5.182

4.  The immediate and delayed effects of diisopropylfluorophosphate injected into the supraoptic nuclei of dogs.

Authors:  H N Duke; M Pickford; J A Watt
Journal:  J Physiol       Date:  1950-04-15       Impact factor: 5.182

5.  The action of acetylcholine in the supraoptic nucleus of the chloralosed dog.

Authors:  M Pickford
Journal:  J Physiol       Date:  1947-07-31       Impact factor: 5.182

6.  Analysis of some central actions of nicotine injected into the cerebral ventricles of cats.

Authors:  G H Hall; E Reit
Journal:  J Physiol       Date:  1966-07       Impact factor: 5.182

7.  An afferent pathway for the selective release of vasopressin in response to carotid occlusion and haemorrhage in the cat.

Authors:  B J Clark; E Silva MR Jr
Journal:  J Physiol       Date:  1967-08       Impact factor: 5.182

8.  Effect of tyrosinase preparations on oxytocin, vasopressin and bradykinin.

Authors:  G W BISSET
Journal:  Br J Pharmacol Chemother       Date:  1962-04

9.  A vasodepressor effect of pentobarbitone sodium.

Authors:  W Feldberg; P G Guertzenstein
Journal:  J Physiol       Date:  1972-07       Impact factor: 5.182

10.  Morphine hyperglycaemia.

Authors:  W Feldberg; K P Gupta
Journal:  J Physiol       Date:  1974-05       Impact factor: 5.182

View more
  6 in total

1.  Cardiovascular effects of activation of central alpha7 and alpha4beta2 nAChRs: a role for vasopressin in anaesthetized rats.

Authors:  C Moore; Y Wang; A G Ramage
Journal:  Br J Pharmacol       Date:  2008-02-25       Impact factor: 8.739

2.  Detoxification and elimination of nicotine by nectar-feeding birds.

Authors:  S Lerch-Henning; E E Du Rand; S W Nicolson
Journal:  J Comp Physiol B       Date:  2017-02-01       Impact factor: 2.200

3.  Effects of cholinoceptor antagonists on the suckling-induced and experimentally evoked release of oxytocin.

Authors:  G Clarke; C H Fall; D W Lincoln; L P Merrick
Journal:  Br J Pharmacol       Date:  1978-07       Impact factor: 8.739

4.  Effects of vasopressin on the circulation, myocardial dynamics, and left ventricular oxygen consumption in the anaesthetized dog.

Authors:  C F Cartheuser; J Komarek
Journal:  Basic Res Cardiol       Date:  1980 Sep-Oct       Impact factor: 17.165

5.  Effect of nicotine on mRNA levels encoding opioid peptides, vasopressin and alpha 3 nicotinic receptor subunit in the rat.

Authors:  V Höllt; G Horn
Journal:  Clin Investig       Date:  1992 Mar-Apr

6.  A cholinergic link in the reflex release of vasopressin by hypotension in the rat.

Authors:  G W Bisset; H S Chowdrey
Journal:  J Physiol       Date:  1984-09       Impact factor: 5.182

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.